Lexicon Pharmaceuticals (LXRX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Lexicon Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$1.20M

Latest Revenue (Q)

$1.65M

Lexicon Pharmaceuticals Revenue by Period


Lexicon Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$1.20M766.19%
2022-12-31$139.00K-53.36%
2021-12-31$298.00K-98.76%
2020-12-31$24.00M-92.55%
2019-12-31$322.07M409.54%
2018-12-31$63.21M-30.03%
2017-12-31$90.33M8.40%
2016-12-31$83.34M-35.90%
2015-12-31$130.01M468.89%
2014-12-31$22.85M928.53%
2013-12-31$2.22M104.04%
2012-12-31$1.09M-41.10%
2011-12-31$1.85M-62.33%
2010-12-31$4.91M-54.13%
2009-12-31$10.70M-66.89%
2008-12-31$32.32M-35.51%
2007-12-31$50.12M-31.15%
2006-12-31$72.80M-3.81%
2005-12-31$75.68M22.58%
2004-12-31$61.74M44.12%
2003-12-31$42.84M21.70%
2002-12-31$35.20M-88.48%
2001-12-31$305.58M2013.47%
2000-12-31$14.46M207.63%
1999-12-31$4.70M-

Lexicon Pharmaceuticals generated $1.20M in revenue during NA 2023, up 766.19% compared to the previous quarter, and up 1.90% compared to the same period a year ago.

Lexicon Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$1.65M45.75%
2024-03-31$1.13M60.97%
2023-12-31$702.00K333.33%
2023-09-30$162.00K-48.90%
2023-06-30$317.00K1220.83%
2023-03-31$24.00K-14.29%
2022-12-31$28.00K-28.21%
2022-09-30$39.00K11.43%
2022-06-30$35.00K-5.41%
2022-03-31$37.00K164.29%
2021-12-31$14.00K-39.13%
2021-09-30$23.00K-90.17%
2021-06-30$234.00K766.67%
2021-03-31$27.00K-86.43%
2020-12-31$199.00K-97.00%
2020-09-30$6.63M-27.60%
2020-06-30$9.16M14.55%
2020-03-31$8.00M-8.34%
2019-12-31$8.73M-97.04%
2019-09-30$294.45M2941.19%
2019-06-30$9.68M5.06%
2019-03-31$9.22M-46.01%
2018-12-31$17.07M148.99%
2018-09-30$6.86M-50.15%
2018-06-30$13.75M-45.44%
2018-03-31$25.21M-23.72%
2017-12-31$33.05M22.66%
2017-09-30$26.94M123.53%
2017-06-30$12.05M-34.11%
2017-03-31$18.29M-20.59%
2016-12-31$23.04M-16.88%
2016-09-30$27.72M37.97%
2016-06-30$20.09M60.79%
2016-03-31$12.49M-90.18%
2015-12-31$127.28M22387.63%
2015-09-30$566.00K50.53%
2015-06-30$376.00K-79.02%
2015-03-31$1.79M-91.66%
2014-12-31$21.48M5026.97%
2014-09-30$419.00K-38.02%
2014-06-30$676.00K144.04%
2014-03-31$277.00K-80.35%
2013-12-31$1.41M492.44%
2013-09-30$238.00K11.21%
2013-06-30$214.00K-40.56%
2013-03-31$360.00K65.14%
2012-12-31$218.00K-41.40%
2012-09-30$372.00K86.93%
2012-06-30$199.00K-33.67%
2012-03-31$300.00K-12.54%
2011-12-31$343.00K-3.38%
2011-09-30$355.00K-36.04%
2011-06-30$555.00K-6.88%
2011-03-31$596.00K-52.43%
2010-12-31$1.25M60.44%
2010-09-30$781.00K-36.66%
2010-06-30$1.23M-24.86%
2010-03-31$1.64M16.22%
2009-12-31$1.41M-33.74%
2009-09-30$2.13M-28.71%
2009-06-30$2.99M-28.29%
2009-03-31$4.17M-34.36%
2008-12-31$6.35M-15.47%
2008-09-30$7.51M-21.47%
2008-06-30$9.57M7.57%
2008-03-31$8.89M-35.60%
2007-12-31$13.81M-

Lexicon Pharmaceuticals generated $1.65M in revenue during Q2 2024, up 45.75% compared to the previous quarter, and up 6862.50% compared to the same period a year ago.

Lexicon Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics$126.33M-
ARDXArdelyx$124.46M$98.24M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
BLRXBioLineRx$4.80M$6.86M
LXRXLexicon Pharmaceuticals$1.20M$1.65M
IBRXImmunityBio$622.00K$1.05M
CWBRCohBar--
XFORX4 Pharmaceuticals-$563.00K
AVROAVROBIO--
DAWNDay One Biopharmaceuticals-$20.07M
ELEVElevation Oncology--
TERNTerns Pharmaceuticals--
OCEAOcean Biomedical--
HEPAHepion Pharmaceuticals--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

LXRX Revenue FAQ


Lexicon Pharmaceuticals's yearly revenue for 2023 was $1.2M, representing an increase of 766.19% compared to 2022. The company's yearly revenue for 2022 was $139K, representing a decrease of -53.36% compared to 2021. LXRX's yearly revenue for 2021 was $298K, representing a decrease of -98.76% compared to 2020.

Lexicon Pharmaceuticals's quarterly revenue for Q2 2024 was $1.65M, a 45.75% increase from the previous quarter (Q1 2024), and a 419.56% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.13M, a 60.97% increase from the previous quarter (Q4 2023), and a 4608.33% increase year-over-year (Q1 2023). LXRX's quarterly revenue for Q4 2023 was $702K, a 333.33% increase from the previous quarter (Q3 2023), and a 2407.14% increase year-over-year (Q4 2022).

Lexicon Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 304.03%, and for the last 5 years (2019-2023) was -99.63%.